Oxitec — a company that seeks to control pest insects through their genetics — has announced that it will invest $9.88 million to mass-produce one billion genetically modified mosquito eggs per week at a new state-of-the-art facility at its United Kingdom headquarters near Oxford.
“Oxitec’s technology represents a paradigm change in combating dangerous Aedes aegypti that threaten more than half of the world’s population, and this factory will better position us to help countries in need of superior solutions in the fight against this invasive mosquito that carries Zika, dengue and other harmful viruses,” said Oxitec CEO Mark Carnegie-Brown.
Read the full post at the Cornell Alliance for Science.
